Boehringer says Pradaxa blood-thinning effect shown to be reversible

FRANKFURT, June 22 (Reuters) - Germany's Boehringer said an experimental drug to reverse the blood-thinning effect of its stroke prevention pill Pradaxa was shown to be effective based on initial results of a late-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.